Vascular Endothelial Growth Factor (VEGF), originally known as vascular permeability factor (VPF), is a family of proteins that stimulate vasculogenesis and angiogenesis. The VEGF family comprises five members: VEGF-A, VEGF-B, VEGF-C, VEGF-D and PGF (placenta growth factor) 1-3. Being the first of the VEGF family members to be discovered, VEGF-A is often simply referred to as VEGF.

The VEGF ELISA Kit provides a quantitative, competitive detection method for measuring melatonin in serum, plasma, and cell culture supernants. This ultra-sensitive assay measures as little as 4 pg /ml of VEGF and provides fully quantitative results.   The ELISA kit is highly specific with 100% cross-reactivity to VEGF 165 with negligible cross-reactivity to related molecules including VEGF 121. With the ability to analyze up to 38 samples in duplicate in 2.5 hours, these kits meet the needs for rapid, high-throughput analysis.

Like many other Enzo Life Sciences ELISA kits, the VEGF ELISA kit is complete, flexible and thoroughly validated. They are supplied with an easy-to-follow protocol, pre-coated microtiter plate and liquid color-coded reagents to save the user time and reduce errors. The break-a-part strip plate design provides flexibility – not having to run all 96-wells at once. Each kit is put through rigorous fit-for-purpose validation and stability testing to ensure high precision, accuracy, sensitivity, and specificity.

The release of the VEGF ELISA kit is the most recent addition to the Enzo portfolio of products for Asthma, Diabetes, Autoimmune, Inflammation, Cancer, Neuroscience, Cardiovascular and Stem Cell research.

For more information on this ELISA kit or other Enzo Life Science products, please visit us at or call us at 1-800-942-0430.

About Enzo Life Sciences

Enzo Life Sciences, Inc. is a wholly owned subsidiary of Enzo Biochem, Inc. headquartered in Farmingdale, New York. The company is focused on providing innovative life science research reagents worldwide based on 40 years of successful experience in building strong international market recognition, implementing outstanding operational capabilities, and establishing a state-of-the-art electronic information and ordering marketplace.

Enzo Life Sciences, Inc. is a recognized leader in labeling and detection technologies across research and diagnostic markets. Our strong portfolio of assay kits, libraries, proteins, antibodies, peptides, and small molecules provides life science researchers tools for target identification/validation, drug discovery, cellular analysis, high content analysis, gene expression analysis, nucleic acid detection, and protein biochemistry and detection.